Internal Medicine, Hematology & Oncology · Corona, CA
NPI
1164478855
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
260 E Ontario Ave, Suite # 101
Corona, CA, 92879
Phone (951) 371-2411
Groups this clinician bills Medicare through
Medicare paid, 2024
$323K
19,361 services
Medicare patients, 2024
155
Average age 72
Drug cost, 2024
$761K
533 prescriptions
Company payments, 2025
$532
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rehana S Baqai was code 99214 (office e&m - established), 188 times for 112 patients. In total Rehana S Baqai billed 19,361 services in 56 codes, and Medicare paid $323K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 188 | 112 | $99.13 | $19K |
| 96127 Behavioral Health Services | Office | 73 | 71 | $3.94 | $288 |
| 99215 Office E&M - Established | Office | 51 | 35 | $133.63 | $6,815 |
| 99205 Office E&M - New | Office | 16 | 16 | $168.28 | $2,692 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 11 | $88.22 | $1,411 |
By year: 2022 $492K for 18,697 services; 2023 $185K for 11,933 services; 2024 $323K for 19,361 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rehana S Baqai prescribed most often to Medicare patients was Anastrozole, with 126 prescriptions and refills. In total Rehana S Baqai wrote 533 Medicare prescriptions that cost $761K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 126 | 359 | 53 | $2,621 |
| Bortezomib Generic | 25 | 25 | Under 11 | $7,692 |
| Hydroxyurea Generic | 21 | 24 | Under 11 | $436 |
| Zarxio Filgrastim-Sndz | 19 | 19 | Under 11 | $28K |
| Tamoxifen Citrate Generic | 19 | 33 | Under 11 | $475 |
| Dexamethasone Sodium Phosphate Generic | 17 | 20 | Under 11 | $119 |
| Retacrit Epoetin Alfa-Epbx | 16 | 16 | Under 11 | $21K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 15 | 15 | Under 11 | $54.1 |
| Cyclophosphamide Generic | 15 | 15 | Under 11 | $11K |
| Sodium Chloride 0.9 % Sodium Chloride | 13 | 13 | Under 11 | $58 |
| Diphenhydramine Hcl Generic | 12 | 15 | Under 11 | $26.69 |
| Acyclovir Generic | 11 | 13 | Under 11 | $39.96 |
Brand drugs: 147 claims; generic drugs: 386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rehana S Baqai $532 ($532 in general payments such as food, travel and fees) from 15 companies. The largest payer was GlaxoSmithKline, LLC. with $93.36.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $93.36 |
| Abbvie Inc. ABBV | 3 | $87.66 |
| Pfizer Inc. PFE | 3 | $67.49 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $34.79 |
| Amgen Inc. AMGN | 1 | $32.72 |
| Celgene Corporation BMY | 1 | $31.96 |
| SpringWorks Therapeutics, Inc. | 1 | $28.52 |
| BeOne Medicines USA, Inc. ONC | 1 | $24.82 |
| Kite Pharma, Inc. GILD | 1 | $22.53 |
| Gilead Sciences, Inc. GILD | 1 | $21.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.